Published in Neuropsychologia on January 01, 2002
Measuring unconscious knowledge: distinguishing structural knowledge and judgment knowledge. Psychol Res (2005) 1.39
The necessity of the medial temporal lobe for statistical learning. J Cogn Neurosci (2014) 1.06
Perceptual priming does not transfer interhemispherically in the acallosal brain. Exp Brain Res (2008) 0.81
New learning of music after bilateral medial temporal lobe damage: evidence from an amnesic patient. Front Hum Neurosci (2014) 0.78
Implicit learning in children with spelling disability: evidence from artificial grammar learning. J Neural Transm (Vienna) (2012) 0.75
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis (2003) 8.00
Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis (2009) 6.17
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis (2008) 6.03
Standardization of cytokine flow cytometry assays. BMC Immunol (2005) 4.55
T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38
A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis (2011) 3.10
Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS (2006) 2.98
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis (2010) 2.98
Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods (2009) 2.78
Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy. J Infect Dis (2011) 2.56
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog (2013) 2.44
Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest (2008) 2.35
Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods (2003) 2.28
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis (2013) 2.23
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis (2012) 2.16
Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods (2006) 2.14
Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog (2013) 2.06
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis (2012) 1.86
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV disease. PLoS One (2010) 1.83
The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci U S A (2013) 1.80
Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. AIDS (2004) 1.75
Performance of plate-based cytokine flow cytometry with automated data analysis. BMC Immunol (2003) 1.66
T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis (2011) 1.64
Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol (2011) 1.62
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1. J Infect Dis (2004) 1.58
Self-regulated learning in simulation-based training: a systematic review and meta-analysis. Med Educ (2015) 1.44
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One (2011) 1.43
The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis (2013) 1.39
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNA. J Infect Dis (2012) 1.30
Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology (2013) 1.24
Loss of T cell responses following long-term cryopreservation. J Immunol Methods (2007) 1.23
The independent effect of drug resistance on T cell activation in HIV infection. AIDS (2006) 1.22
Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. J Infect Dis (2011) 1.15
A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. J Acquir Immune Defic Syndr (2012) 1.09
HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis (2011) 1.03
High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One (2009) 1.02
Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow. Pediatr Blood Cancer (2010) 1.02
Directed self-regulated learning versus instructor-regulated learning in simulation training. Med Educ (2012) 1.02
A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. AIDS (2014) 0.98
Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects. PLoS One (2013) 0.96
A CMV DNA vaccine primes for memory immune responses to live-attenuated CMV (Towne strain). Vaccine (2009) 0.96
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection. AIDS (2013) 0.95
Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease. AIDS (2014) 0.95
Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12. Vaccine (2006) 0.92
Geriatric trauma: demographics, injuries, and mortality. J Orthop Trauma (2012) 0.92
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers. AIDS (2013) 0.92
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One (2009) 0.90
IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery. J Clin Immunol (2010) 0.89
Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients. J Clin Virol (2006) 0.87
Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. AIDS Res Ther (2011) 0.86
Immune activation, CD4+ T cell counts, and viremia exhibit oscillatory patterns over time in patients with highly resistant HIV infection. PLoS One (2011) 0.86
Development of cytomegalovirus (CMV) immune recovery uveitis is associated with Th17 cell depletion and poor systemic CMV-specific T cell responses. Clin Infect Dis (2010) 0.86
Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis (2008) 0.84
HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol (2011) 0.82
Real-life-type problem solving in Tourette syndrome. Cogn Behav Neurol (2003) 0.82
Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. J Acquir Immune Defic Syndr (2014) 0.80
HIV-producing T cells in cerebrospinal fluid. J Acquir Immune Defic Syndr (2004) 0.80
Synthesis of N,N'-disubstituted 3-aminobenzo[c] and [d]azepin-2-ones as potent and specific farnesyl transferase inhibitors. Bioorg Med Chem Lett (2004) 0.80
Cortisol patterns are associated with T cell activation in HIV. PLoS One (2013) 0.80
Endothelial cell high-enrichment from endovascular biopsy sample by laser capture microdissection and fluorescence activated cell sorting. J Biotechnol (2014) 0.79
Clinical findings and prognostic factors for dogs undergoing cholecystectomy for gall bladder mucocele. Vet Surg (2013) 0.79
Acute propafenone toxicity after two exposures at standard dosing. Can J Cardiol (2010) 0.77
Social cognition in Tourette's syndrome: intact theory of mind and impaired inhibitory functioning. J Autism Dev Disord (2004) 0.77
Correction: A novel minimally-invasive method to sample human endothelial cells for molecular profiling. PLoS One (2015) 0.75
Using the Entrustable Professional Activities Framework in the Assessment of Procedural Skills. J Grad Med Educ (2017) 0.75
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog (2016) 0.75
Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. PLoS Pathog (2017) 0.75
A Novel Minimally-Invasive Method to Sample Human Endothelial Cells for Molecular Profiling. PLoS One (2015) 0.75
Immunologic profiles distinguish aviremic HIV-infected adults. AIDS (2016) 0.75
Long-lasting antioxidant protection: a regenerable BHA analogue. J Org Chem (2010) 0.75
Mucinous adenocarcinoma of the breast metastatic to the placenta. Pathology (2010) 0.75
Parallel liquid synthesis of N,N'-Disubstituted 3-amino azepin-2-ones as potent and specific farnesyl transferase inhibitors. Bioorg Med Chem (2003) 0.75